Improving the treatment of migraine and epilepsy comorbidity

Abstract

The article is aimed to determine the specific features of common neurological diseases, migraine and epilepsy comorbidity, correct selection of drugs and increasing the effectiveness of treatment in cases where migraine and epilepsy are comorbid. A total of 60 (100%) patients were recruited during the study. 30 of them (the main group) were diagnosed with migraine and epilepsy and were prescribed lamotrigine, and 30 patients (the control group) were diagnosed with migraine and epilepsy and were prescribed convulex. The clinical course of migraine, the level of cognitive disorders, the quality of life of patients, and the level of limitation of daily work were studied in patients of both groups.